Compare Piramal Healthcare with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs DR. REDDYS LAB - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES DR. REDDYS LAB PIRAMAL ENTERPRISES/
DR. REDDYS LAB
 
P/E (TTM) x 17.7 40.2 44.2% View Chart
P/BV x 1.2 5.4 22.5% View Chart
Dividend Yield % 1.9 0.4 436.4%  

Financials

 PIRAMAL ENTERPRISES   DR. REDDYS LAB
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
DR. REDDYS LAB
Mar-19
PIRAMAL ENTERPRISES/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3,3032,875 114.9%   
Low Rs1,7971,888 95.2%   
Sales per share (Unadj.) Rs716.5930.2 77.0%  
Earnings per share (Unadj.) Rs79.7117.4 67.9%  
Cash flow per share (Unadj.) Rs107.9185.8 58.1%  
Dividends per share (Unadj.) Rs28.0020.00 140.0%  
Dividend yield (eoy) %1.10.8 130.8%  
Book value per share (Unadj.) Rs1,477.5844.4 175.0%  
Shares outstanding (eoy) m184.45166.07 111.1%   
Bonus/Rights/Conversions ISESOP-  
Price / Sales ratio x3.62.6 139.0%   
Avg P/E ratio x32.020.3 157.7%  
P/CF ratio (eoy) x23.612.8 184.3%  
Price / Book Value ratio x1.72.8 61.2%  
Dividend payout %35.117.0 206.3%   
Avg Mkt Cap Rs m470,292395,496 118.9%   
No. of employees `0007.822.0 35.6%   
Total wages/salary Rs m22,50433,562 67.1%   
Avg. sales/employee Rs Th16,899.47,032.8 240.3%   
Avg. wages/employee Rs Th2,877.71,527.9 188.3%   
Avg. net profit/employee Rs Th1,879.9887.7 211.8%   
INCOME DATA
Net Sales Rs m132,153154,482 85.5%  
Other income Rs m3,1283,375 92.7%   
Total revenues Rs m135,281157,857 85.7%   
Gross profit Rs m66,29031,782 208.6%  
Depreciation Rs m5,20211,348 45.8%   
Interest Rs m44,097889 4,960.3%   
Profit before tax Rs m20,11922,920 87.8%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,6113,858 223.2%   
Profit after tax Rs m14,70119,500 75.4%  
Gross profit margin %50.220.6 243.8%  
Effective tax rate %42.816.8 254.3%   
Net profit margin %11.112.6 88.1%  
BALANCE SHEET DATA
Current assets Rs m122,742111,101 110.5%   
Current liabilities Rs m310,81058,973 527.0%   
Net working cap to sales %-142.333.7 -421.7%  
Current ratio x0.41.9 21.0%  
Inventory Days Days2379 29.1%  
Debtors Days Days3994 41.2%  
Net fixed assets Rs m116,904101,245 115.5%   
Share capital Rs m369830 44.4%   
"Free" reserves Rs m272,161139,406 195.2%   
Net worth Rs m272,530140,236 194.3%   
Long term debt Rs m270,19622,000 1,228.2%   
Total assets Rs m856,261224,656 381.1%  
Interest coverage x1.526.8 5.4%   
Debt to equity ratio x1.00.2 632.0%  
Sales to assets ratio x0.20.7 22.4%   
Return on assets %6.99.1 75.7%  
Return on equity %5.413.9 38.8%  
Return on capital %12.414.9 83.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m15,20088,673 17.1%   
Fx outflow Rs m4,88919,104 25.6%   
Net fx Rs m10,31269,569 14.8%   
CASH FLOW
From Operations Rs m-115,97528,704 -404.0%  
From Investments Rs m-8,265-7,727 107.0%  
From Financial Activity Rs m107,525-21,326 -504.2%  
Net Cashflow Rs m-16,650-314 5,302.6%  

Share Holding

Indian Promoters % 52.9 25.5 207.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 5.4 74.1%  
FIIs % 26.6 35.3 75.4%  
ADR/GDR % 0.0 18.5 -  
Free float % 16.5 15.3 107.8%  
Shareholders   93,274 75,885 122.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   TTK HEALTHCARE  UNICHEM LAB  WYETH LTD  ELDER PHARMA  ALEMBIC LTD  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 225 Points Higher; Metal and Banking Stocks Witness Buying(Closing)

Extending gains to the fourth consecutive session, Indian share markets witnessed buying interest throughout the day today and ended higher.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver?(Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

Forget the Nifty and Sensex for the Next 1 or 2 Years and Focus on These Stocks(Profit Hunter)

Aug 6, 2020

Stocks from the essential small cap space are likely to be outperformers over the next 1 or 2 years.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 11, 2020 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS